Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Oct;40(10):1906–1914. doi: 10.1172/JCI104415

THE URICOSURIA AND OROTIC ACIDURIA INDUCED BY 6-AZAURIDINE*

Harold J Fallon 1,†, Emil Frei III 1, Jerome Block 1, J Edwin Seegmiller 1
PMCID: PMC290889  PMID: 13891472

Full text

PDF
1906

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNS J. J., YU T. F., BERGER L., GUTMAN A. B. Zoxazolamine: physiological disposition, uricosuric properties. Am J Med. 1958 Sep;25(3):401–408. doi: 10.1016/0002-9343(58)90079-2. [DOI] [PubMed] [Google Scholar]
  2. DE VERDIER C. H. The incorporation of labelled phosphate into different compounds in the rat kidney; the effect of parathyroid extract on an in vivo system. Acta Physiol Scand. 1957 Apr 10;39(1):1–11. doi: 10.1111/j.1748-1716.1957.tb01403.x. [DOI] [PubMed] [Google Scholar]
  3. ELLISON R. R., TAN C. T., MURPHY M. L., KRAKOFF I. H. [Clinical investigations of 6-azathymine: a thymine analog]. Cancer Res. 1960 May;20:435–442. [PubMed] [Google Scholar]
  4. GOLD G. L., FRITZ R. D. Hyperuricemia associated with the treatment of acute leukemia. Ann Intern Med. 1957 Sep;47(3):428–434. doi: 10.7326/0003-4819-47-3-428. [DOI] [PubMed] [Google Scholar]
  5. GREENBAUM D., STONE H. F. H. Dangers of uric-acid excretion during treatment of leukaemia and lymphosarcoma. Lancet. 1959 Jan 10;1(7063):73–75. doi: 10.1016/s0140-6736(59)91140-7. [DOI] [PubMed] [Google Scholar]
  6. GUTMAN A. B., YU T. F. Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. Bull N Y Acad Med. 1958 May;34(5):287–296. [PMC free article] [PubMed] [Google Scholar]
  7. HABERMANN V. Elimination by the urine of orotic acid and orotidine in man after application of 6-azauracil. Biochim Biophys Acta. 1960 Sep 9;43:137–138. doi: 10.1016/0006-3002(60)90420-0. [DOI] [PubMed] [Google Scholar]
  8. HALLANGER L. E., LAAKSO J. W., SCHULTZE M. O. Orotic acid in milk. J Biol Chem. 1953 May;202(1):83–89. [PubMed] [Google Scholar]
  9. HANDSCHUMACHER R. E. Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate. J Biol Chem. 1960 Oct;235:2917–2919. [PubMed] [Google Scholar]
  10. HANDSCHUMACHER R. E., PASTERNAK C. A. Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracil. Biochim Biophys Acta. 1958 Nov;30(2):451–452. doi: 10.1016/0006-3002(58)90088-x. [DOI] [PubMed] [Google Scholar]
  11. HUGULEY C. M., Jr, BAIN J. A., RIVERS S. L., SCOGGINS R. B. Refractory megaloblastic anemia associated with excretion of orotic acid. Blood. 1959 Jun;14(6):615–634. [PubMed] [Google Scholar]
  12. INGBAR S. H., KASS E. H., BURNETT C. H., RELMAN A. S., BURROWS B. A., SISSON J. H. The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J Lab Clin Med. 1951 Oct;38(4):533–541. [PubMed] [Google Scholar]
  13. JAFFE J. J., HANDSCHUMACHER R. E., WELCH A. D. Studies on the carcinostatic activity in mice of 6-azauracil riboside (azauridine), in comparison with that of 6-azauracil. Yale J Biol Med. 1957 Dec;30(3):168–175. [PMC free article] [PubMed] [Google Scholar]
  14. LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
  15. LIEBERMAN I., KORNBERG A., SIMMS E. S. Enzymatic synthesis of pyrimidine nucleotides; orotidine-5'-phosphate and uridine-5'-phosphate. J Biol Chem. 1955 Jul;215(1):403–451. [PubMed] [Google Scholar]
  16. PARDEE A. B., YATES R. A. Control of pyrimidine biosynthesis in Escherichia coli by a feed-back mechanism. J Biol Chem. 1956 Aug;221(2):757–770. [PubMed] [Google Scholar]
  17. PARDEE A. B., YATES R. A. Pyrimidine biosynthesis in Escherichia coli. J Biol Chem. 1956 Aug;221(2):743–756. [PubMed] [Google Scholar]
  18. PASTERNAK C. A., HANDSCHUMACHER R. E. The biochemical activity of 6-azauridine: interference with pyrimidine metabolism in transplantable mouse tumors. J Biol Chem. 1959 Nov;234:2992–2997. [PubMed] [Google Scholar]
  19. SANDBERG A. A., CARTWRIGHT G. E., WINTROBE M. M. Studies on leukemia. I. Uric acid excretion. Blood. 1956 Feb;11(2):154–166. [PubMed] [Google Scholar]
  20. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SMITH L. H., Jr, BAKER F. A., SULLIVAN M. Pyrimidine metabolism in man. II. Studies of leukemic cells. Blood. 1960 Mar;15:360–369. [PubMed] [Google Scholar]
  22. TALBOTT J. H. Gout and blood dyscrasias. Medicine (Baltimore) 1959 May;38(2):173–205. doi: 10.1097/00005792-195905000-00004. [DOI] [PubMed] [Google Scholar]
  23. WALSER M., DAVIDSON D. G., ORLOFF J. The renal clearance of alkali-stable inulin. J Clin Invest. 1955 Oct;34(10):1520–1523. doi: 10.1172/JCI103204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. WELCH A. D., HANDSCHUMACHER R. E., FINCH S. C., JAFFE J. J., CARDOSO S. S., CALABRESI P. A synopsis of recent investigations of 6-azauridine (NSC-32074). Cancer Chemother Rep. 1960 Nov;9:39–46. [PubMed] [Google Scholar]
  25. WYNGAARDEN J. B. The effect of phenylbutazone on uric acid metabolism in two normal subjects. J Clin Invest. 1955 Feb;34(2):256–262. doi: 10.1172/JCI103078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. YATES R. A., PARDEE A. B. Control by uracil of formation of enzymes required for orotate synthesis. J Biol Chem. 1957 Aug;227(2):677–692. [PubMed] [Google Scholar]
  27. YU T. F., GUTMAN A. B. Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med. 1955 Nov;90(2):542–547. doi: 10.3181/00379727-90-22094. [DOI] [PubMed] [Google Scholar]
  28. YU T. F., SIROTA J. H., GUTMAN A. B. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES